Financials
Financial year 2025
MEDIOX from Wijnegem, company number BE0420589723, closed financial year 2025 with a result of € -6,017 after tax. For that financial year MEDIOX recorded a gross margin of € -5,378 and equity of € 132,792. Compared with financial year 2024, the result moved from € 22,672 to € -6,017. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 132,792
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6,017
▼ still € 22,672 profit in 2024
Profit after tax over the fiscal year.
€ 12,838
▼ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 114,200.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 56,299
▲ 157% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 47,708 | € 39,489 | € 31,327 | € -5,378 | ▼ € 36,705 |
| Profit after taxes | € 35,584 | € 29,070 | € 22,672 | € -6,017 | ▼ € 28,689 |
| Equity | € 87,066 | € 116,136 | € 138,808 | € 132,792 | ▼ 4% |
| Total debts | € 96,214 | € 109,155 | € 73,566 | € 81,841 | ▲ 11% |
| Cash | € 28,145 | € 64,881 | € 45,128 | € 12,838 | ▼ 72% |
| Retained profit | € 68,474 | € 97,544 | € 120,216 | € 114,200 | ▼ 5% |
| Balance sheet total | € 183,281 | € 225,292 | € 212,374 | € 214,632 | ▲ 1% |
Key figures of MEDIOX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDIOX?
What happened at MEDIOX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6,017 (▼ € 28,689 vs 2024). filed late Source: NBB ↗
- Dirk Christiaen became a director. NBB
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 35,584 profit in 2022 to € 6,017 loss in 2025.
Paid € 29,183 in corporate taxes since 2022.
Best year ever: 2022, with € 35,584 profit.
Management
The stake of DINAMAX-INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MEDIOXBehind MEDIOX is Dirk Christiaen. The shares are held by DINAMAX-INVEST (26%).
Directors
According to the 2025 annual accounts
since 2011
Shareholders
26%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Bijkhoevelaan 8
2110 Wijnegem
Amerikalei 168
2000 Antwerpen
Active since 22 May 1980
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0420.589.723
- VAT number
- BE 0420.589.723
- Registered office
- Bijkhoevelaan 8, 2110 Wijnegem
- Names & denominations
- MEDIOX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 May 1980
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van geneesmiddelen
Opslag
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels